112 results
Opportunistic Infections in HIV/AIDS: Syndromic Approach

WuidQ: Washington University ID Questions @WuidQ

#Opportunistic #Infections #OIs #HIVAIDS #Differential #Diagnosis
Opportunistic Infections ... in HIV/AIDS: Syndromic ... Questions @WuidQ #Opportunistic ... Diagnosis #Systems #Syndromes ... #Syndromic
Syndromic Approach to Opportunistic Infections in HIV/AIDS: 

WuidQ: Washington University ID Questions @WuidQ

#Opportunistic #Infections #OIs #HIVAIDS
Syndromic Approach ... to Opportunistic ... Questions @WuidQ #Opportunistic ... Diagnosis #Systems #Syndromes ... #Syndromic
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #OIs #HIVAIDS #IDSA
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #OIs #HIVAIDS #IDSA
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Guidelines - Invasive syndromes ... or colonizing syndromes ... #medications #IDSA
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... PO (or 400 mg IV ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA ... Treatment #management #opportunistic
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Osteomyelitis - IDSA ... #Parenteral #IV ... #pharmacology #idsa
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... Treatment #management #opportunistic
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... stibogluconate) 20 mg/kg IV ... Treatment #management #opportunistic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 400 mg) PO or IV ... candida #mucosal #IDSA ... Treatment #management #opportunistic